Bicocca Open Archive

Logo unimib boa
QUARTI TREVANO, FOSCA ANNA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.500
AS - Asia 11.832
EU - Europa 8.256
SA - Sud America 1.742
Continente sconosciuto - Info sul continente non disponibili 670
AF - Africa 292
OC - Oceania 22
Totale 44.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.418
SG - Singapore 3.883
CN - Cina 2.404
VN - Vietnam 2.180
IT - Italia 2.116
HK - Hong Kong 1.474
RU - Federazione Russa 1.336
BR - Brasile 1.308
DE - Germania 1.166
SE - Svezia 956
CA - Canada 864
IE - Irlanda 675
UA - Ucraina 465
GB - Regno Unito 412
BD - Bangladesh 374
FR - Francia 339
IN - India 333
KR - Corea 243
FI - Finlandia 202
AR - Argentina 150
IQ - Iraq 135
AT - Austria 134
ID - Indonesia 133
TR - Turchia 112
ZA - Sudafrica 97
MX - Messico 87
PK - Pakistan 80
JP - Giappone 79
NL - Olanda 74
EC - Ecuador 68
PL - Polonia 68
ES - Italia 67
SA - Arabia Saudita 65
PH - Filippine 63
CO - Colombia 62
VE - Venezuela 58
DK - Danimarca 43
UZ - Uzbekistan 43
MY - Malesia 36
KE - Kenya 33
JM - Giamaica 29
EG - Egitto 27
CZ - Repubblica Ceca 26
BE - Belgio 25
TN - Tunisia 25
CL - Cile 24
MA - Marocco 24
PY - Paraguay 24
ET - Etiopia 23
AU - Australia 22
CR - Costa Rica 21
JO - Giordania 20
LT - Lituania 20
NP - Nepal 20
HN - Honduras 19
AE - Emirati Arabi Uniti 16
PE - Perù 16
DZ - Algeria 15
RO - Romania 15
BO - Bolivia 14
AL - Albania 13
AZ - Azerbaigian 13
CH - Svizzera 13
UY - Uruguay 13
BG - Bulgaria 12
EE - Estonia 12
IR - Iran 12
LB - Libano 12
TT - Trinidad e Tobago 11
BY - Bielorussia 10
KZ - Kazakistan 10
NI - Nicaragua 10
TW - Taiwan 10
HU - Ungheria 9
LK - Sri Lanka 9
MK - Macedonia 9
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
PT - Portogallo 8
GE - Georgia 7
IL - Israele 7
PA - Panama 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
KW - Kuwait 6
NG - Nigeria 6
OM - Oman 6
RS - Serbia 6
TH - Thailandia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
KG - Kirghizistan 5
SV - El Salvador 5
EU - Europa 4
MU - Mauritius 4
NO - Norvegia 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
Totale 43.581
Salva come PNG Salva come JPEG
Città #
Singapore 2.237
Ann Arbor 2.182
Ashburn 2.130
Hong Kong 1.448
San Jose 1.380
Fairfield 986
Woodbridge 936
Houston 719
Frankfurt am Main 706
Milan 668
Ho Chi Minh City 655
Dublin 638
Toronto 638
Dallas 599
Chandler 573
Hanoi 529
Wilmington 518
New York 477
Jacksonville 474
Hefei 467
Santa Clara 387
Seattle 382
Beijing 359
Los Angeles 355
Chicago 345
Dearborn 318
Cambridge 308
Council Bluffs 308
Princeton 249
Seoul 233
The Dalles 228
Rome 197
Boardman 194
Lauterbourg 156
Moscow 150
Shanghai 124
Lawrence 123
Altamura 120
São Paulo 118
Phoenix 116
Nanjing 114
Buffalo 110
Vienna 110
Atlanta 107
Da Nang 96
Orem 96
Munich 89
Columbus 81
Helsinki 77
Haiphong 75
Lachine 73
San Diego 72
Jakarta 71
Guangzhou 66
Brooklyn 65
Denver 64
London 56
Baghdad 55
Chennai 53
Lissone 52
Tokyo 52
Rio de Janeiro 50
Warsaw 50
San Francisco 49
Montreal 47
Dong Ket 44
Nuremberg 44
Andover 42
Hangzhou 42
Turin 41
Figino 40
Quận Bình Thạnh 40
Nanchang 38
Tashkent 38
Johannesburg 37
Changsha 36
Ha Long 36
Salt Lake City 36
Tianjin 36
Turku 36
Philadelphia 34
Can Tho 31
Dhaka 31
Düsseldorf 31
Hebei 31
Hải Dương 31
Naples 31
Mumbai 29
Boston 28
Zhengzhou 28
Ninh Bình 27
Vũng Tàu 27
Biên Hòa 26
Fremont 26
Brasília 25
Kent 25
Memphis 25
Thái Nguyên 25
Belo Horizonte 24
Falls Church 24
Totale 26.705
Salva come PNG Salva come JPEG
Nome #
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 769
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 625
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 510
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 493
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 486
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 462
Heart rate as a sympathetic marker during acute adrenergic challenge 452
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 414
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 362
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 355
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 354
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 353
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 340
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 339
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 334
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 334
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 328
Neurogenic abnormalities in masked hypertension 318
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 318
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 304
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 304
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 303
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives 299
Threshold and Target for Blood Pressure Lowering in the Elderly 298
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 297
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 297
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 297
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 296
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome 293
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 293
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 292
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 289
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 289
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 287
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 287
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 284
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 284
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 279
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 276
New onset left atrial dilatation in the general population: A quarter-century follow-up 275
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 274
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 274
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 273
Iron overload exerts sympathoexcitatory effects in men with essential hypertension: microneurogtaphic evidence 272
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 271
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 270
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 269
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 266
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 263
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 263
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 261
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 261
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 261
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 261
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 260
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome 259
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 258
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 257
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 255
Diurnal blood pressure variation and sympathetic activity 255
Incident Left Ventricular Hypertrophy in Masked Hypertension 255
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study 252
Hypertension, antihypertensive treatment and stroke prevention 250
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 249
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 248
Should white-coat hypertension in diabetes be treated? Pro 248
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 248
Long-term risk of sustained hypertension in white-coat or masked hypertension 246
Early sympathetic activation in the initial clinical stages of chronic renal failure 246
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 244
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 242
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 242
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe 240
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 238
Sympathetic activation in congestive heart failure: an updated overview 238
Baroreflex function in hypertension: consequences for antihypertensive therapy 235
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs 235
The "J curve" problem revisited: old and new findings 233
Early sympathetic activation in mild renal failure 233
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 233
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 231
Blood pressure lowering effects of Rimonabant in obesità-related hypertension 230
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 229
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 228
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis 226
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 225
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 224
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 224
Left ventricular hypertrophy in isolated and dual masked hypertension 224
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 224
Blood pressure control in resistant hypertension: new therapeutic options 223
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 221
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 221
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database 220
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 220
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 220
Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study 218
Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population 216
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 216
Effects of Renal Denervation on Sympathetic Nerve Traffic and Correlates in Drug-Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis 211
Totale 28.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.464 0 0 0 201 177 162 110 83 110 128 195 298
2022/20232.814 320 813 274 271 165 453 48 157 159 20 89 45
2023/20242.231 56 56 112 120 298 501 387 74 252 67 51 257
2024/20256.380 321 721 250 268 518 185 299 278 607 979 723 1.231
2025/202617.469 2.287 1.440 1.433 1.748 1.576 825 2.174 752 1.243 1.461 1.176 1.354
2026/20274.573 616 1.267 2.181 509 0 0 0 0 0 0 0 0
Totale 44.314